Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 211–225 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5293 CHAT Gene Congenital Myasthenic Syndrome Genetic Test This genetic test analyzes the CHAT gene for mutations associated with congenital myasthenic syndrome.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CHAT gene sequence", "Pathogenic variants in CHAT gene"] Parameters [] Preparation ["No special preparation needed", "Mandatory genetic counseling session required"] Indications ["Clinical suspicion of congenital myasthenic syndrome", "Family history of congenital myasthenic syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 95810-1 ICD-10: G70.2 Clinical summary This genetic test analyzes the CHAT gene for mutations associated with congenital myasthenic syndrome.
TEST-2008 CHEK2 Gene Li‑Fraumeni Syndrome Type 2 Genetic Test This genetic test evaluates the CHEK2 gene for variants associated with an increased risk of developing certain cancers, particularly hereditary breast, colorectal, and prostate ca...	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	21–28 Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CHEK2 gene variants", "Single nucleotide variants (SNVs)", "Insertions/Deletions (Indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Individuals with a personal or family history suggestive of hereditary cancer syndromes", "Assessment of cancer predisposition", "Guiding personalized cancer screening and prevention strategies"] Measurement technique Confirm with laboratory Codes LOINC: 92930-2 ICD-10: Z15.09 Clinical summary This genetic test evaluates the CHEK2 gene for variants associated with an increased risk of developing certain cancers, particularly hereditary breast, colorectal, and prostate cancers.
TEST-3602 CHN1 Gene Sequencing for Duane Retraction Syndrome Test This test analyzes the CHN1 gene for pathogenic variants associated with Duane retraction syndrome.	Peripheral whole blood (5 ml in EDTA tube) or saliva (Oragene kit)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHN1 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected Duane retraction syndrome", "Family history of Duane retraction syndrome", "Need for genetic counseling regarding recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: H50.81 Clinical summary This test analyzes the CHN1 gene for pathogenic variants associated with Duane retraction syndrome.
TEST-2395 CHRM3 Gene (Prune Belly Syndrome) Genetic Test This test evaluates the CHRM3 gene for pathogenic variants associated with Prune Belly Syndrome.	Whole Blood, Extracted DNA, or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHRM3 gene", "Single nucleotide variants (SNVs)", "Insertions/Deletions (Indels)", "Copy number changes"] Parameters [] Preparation ["No fasting required.", "No medication changes required."] Indications ["Diagnosis confirmation of Prune Belly Syndrome", "Family planning", "Paediatric surgical planning"] Measurement technique Confirm with laboratory Codes LOINC: 86654-1 ICD-10: Q79.4 Clinical summary This test evaluates the CHRM3 gene for pathogenic variants associated with Prune Belly Syndrome.
TEST-4436 CHRNB2 Gene Epilepsy (Nocturnal Frontal Lobe Type 3) Genetic Test This genetic test identifies pathogenic variants in the CHRNB2 gene associated with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).	EDTA whole blood or FTA card	3–4 weeks (expedited clinical reporting)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHRNB2 gene", "Molecular diagnosis of ADNFLE"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "99.9% (detects SNVs, indels, and deep intronic splicing variants)"}, {"name": "Methodology", "reference_range": "NGS plus optional RNA-Seq (full exon-level resolution)"}] Preparation ["No special preparation required", "Inform phlebotomist of medications, especially anticoagulants"] Indications ["Suspected Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)", "Confirmation of molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94862-1 ICD-10: G40.0 Clinical summary This genetic test identifies pathogenic variants in the CHRNB2 gene associated with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).
TEST-4785 CHRND Gene Lethal Multiple Pterygium Syndrome Genetic Test This test evaluates the CHRND gene for pathogenic variants associated with lethal multiple pterygium syndrome (LMPS). It identifies mutations that cause this severe congenital diso...	Peripheral Blood (Whole Blood)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CHRND gene pathogenic variants", "Lethal Multiple Pterygium Syndrome (LMPS) risk"] Parameters [] Preparation ["No specific fasting required", "Avoid sample collection during active infection"] Indications ["Diagnosis of suspected LMPS", "Carrier screening for LMPS", "Prenatal diagnosis of LMPS"] Measurement technique Confirm with laboratory Codes LOINC: 55225-7 ICD-10: Q87.0 Clinical summary This test evaluates the CHRND gene for pathogenic variants associated with lethal multiple pterygium syndrome (LMPS). It identifies mutations that cause this severe congenital disorder.
TEST-610 Chromium Random Urine Test This test measures the amount of chromium excreted in urine, providing an indication of recent exposure to the metal.	Random urine	Next day (sample received by 6 PM)	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Urinary chromium excretion", "Trace metal exposure"] Parameters [{"name": "Chromium", "reference_range": "Typically >1.4 µg/g creatinine indicates exposure"}] Preparation ["Avoid gadolinium- or iodine-based contrast media for 96 hours before collection", "No fasting required"] Indications ["Occupational health screening (metal plating, welding, leather tanning)", "Evaluation of potential environmental or dietary chromium overload", "Monitoring renal handling of trace metals"] Measurement technique Confirm with laboratory Codes LOINC: 2691-9 ICD-10: Z57.2, R82.99 Clinical summary This test measures the amount of chromium excreted in urine, providing an indication of recent exposure to the metal.
TEST-606 Chromium, 24-Hour Urine Test This diagnostic test evaluates the total concentration of chromium excreted in the urine over a 24-hour period.	24-Hour Urine	Next-Day Report	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Total urinary chromium concentration", "Time-integrated chromium excretion"] Parameters [{"name": "Chromium", "reference_range": null}] Preparation ["Refrain from administering contrast media (Gadolinium or Iodine-containing agents) for 96 hours prior to collection.", "Use the provided metal-free 24-hour urine collection kit and follow instructions exactly.", "Store the specimen refrigerated (2–8 °C) or frozen (−20 °C) until courier pickup."] Indications ["Monitoring occupational exposure", "Diagnosing industrial diseases", "Assessing nutritional status", "Evaluating detoxification status"] Measurement technique Confirm with laboratory Codes LOINC: 15011-9 ICD-10: T56.891A, Z77.029 Clinical summary This diagnostic test evaluates the total concentration of chromium excreted in the urine over a 24-hour period.
TEST-611 Chromogranin A (CGA) Test This diagnostic test evaluates serum levels of Chromogranin A, a protein released by neuroendocrine cells, to aid in the detection and monitoring of neuroendocrine tumors.	Serum or Plasma (EDTA)	Same day (sample received before 11 AM)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromogranin A protein levels", "Neuroendocrine cell activity"] Parameters [{"name": "Chromogranin A", "reference_range": null}] Preparation ["Temporarily discontinue proton pump inhibitors (e.g., omeprazole) for 14 days prior, under physician supervision.", "Fasting is not required, but follow specific doctor instructions."] Indications ["Diagnosis of neuroendocrine tumors (NETs)", "Monitoring NET progression", "Evaluating response to NET therapy"] Measurement technique Confirm with laboratory Codes LOINC: 104619-7 ICD-10: C7A.00 Clinical summary This diagnostic test evaluates serum levels of Chromogranin A, a protein released by neuroendocrine cells, to aid in the detection and monitoring of neuroendocrine tumors.
TEST-5359 CIITA Gene Test This genetic test evaluates the CIITA gene for mutations causing Bare Lymphocyte Syndrome Type II (BLS II), a severe primary immunodeficiency.	Whole Blood (EDTA) or FTA Card (finger-prick for paediatric)	21–28 Calendar Days (Expedited 14 days available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CIITA gene sequence (coding exons, splice-site junctions)", "Single-nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy-number variations (CNVs)"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}, {"name": "Analytical Sensitivity", "reference_range": ">99.8%"}, {"name": "Gene Coverage", "reference_range": "Full Gene Coverage (Exons + Splice Sites + CNV)"}] Preparation ["No specific fasting required", "Inform lab of any known EDTA or latex allergies"] Indications ["Suspected Bare Lymphocyte Syndrome Type II (BLS II)", "Recurrent opportunistic infections (e.g., Pneumocystis jirovecii pneumonia, persistent candidiasis)", "Severe eczema unresponsive to standard therapy", "Hypogammaglobulinemia", "Absent HLA-DR expression on flow cytometry"] Measurement technique Confirm with laboratory Codes LOINC: 81247-8 ICD-10: D81.6 Clinical summary This genetic test evaluates the CIITA gene for mutations causing Bare Lymphocyte Syndrome Type II (BLS II), a severe primary immunodeficiency.
TEST-5468 CISD2 Gene (Wolfram Syndrome Type 2) Genetic Test This test identifies pathogenic variants in the CISD2 gene associated with Wolfram syndrome type 2.	Peripheral Whole Blood (EDTA)	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CISD2 gene", "Coding region and splice sites of the CISD2 gene"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Individuals with clinical features suggestive of Wolfram syndrome type 2", "Family cascade screening for relatives of affected individuals", "Carrier screening in families with a known history of WFS2"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: E13.8 Clinical summary This test identifies pathogenic variants in the CISD2 gene associated with Wolfram syndrome type 2.
TEST-4084 CITED2 Gene Ventricular Septal Defect Type 2 Genetic Test This genetic test evaluates the CITED2 gene for variants associated with Ventricular Septal Defect Type 2.	Whole Blood (Venipuncture), Extracted DNA, or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CITED2 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["Maintain prescribed therapies unless directed otherwise by physician", "Coordinate test timing and medication adjustments with cardiologist"] Indications ["Suspected or confirmed Ventricular Septal Defect Type 2", "Family history of VSD2", "Genetic counseling for congenital heart disease"] Measurement technique Confirm with laboratory Codes LOINC: 81677-8 ICD-10: Q21.0, Z15.09, Z82.79 Clinical summary This genetic test evaluates the CITED2 gene for variants associated with Ventricular Septal Defect Type 2.
TEST-659 CK (CPK) Isoenzyme Electrophoresis Test This diagnostic test evaluates the specific isoforms of creatine kinase (CK) in serum to differentiate between cardiac, skeletal, and brain muscle injury.	Serum	Same day (sample received by 9 AM)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CK-MM (Skeletal Muscle Isoform)", "CK-MB (Cardiac Muscle Isoform)", "CK-BB (Brain Isoform)"] Parameters [{"name": "CK-MM", "reference_range": null}, {"name": "CK-MB", "reference_range": null}, {"name": "CK-BB", "reference_range": null}] Preparation ["No fasting required", "Avoid strenuous exercise for 24 hours prior", "Inform phlebotomist of all current medications"] Indications ["Suspected acute myocardial infarction (heart attack)", "Evaluation of muscle injury (myopathy, rhabdomyolysis)", "Confirmation of equivocal troponin results", "Identification of muscular dystrophy carriers"] Measurement technique Confirm with laboratory Codes LOINC: 25337-4 ICD-10: I21.9, G71.0, Z15.01 Clinical summary This diagnostic test evaluates the specific isoforms of creatine kinase (CK) in serum to differentiate between cardiac, skeletal, and brain muscle injury.
TEST-663 CKD (Chronic Kidney Disease) Management Panel Test This diagnostic test evaluates kidney function and damage markers, including creatinine, estimated glomerular filtration rate (eGFR), and urine albumin-to-creatinine ratio (ACR).	Peripheral whole blood (Serum), First-morning mid-stream urine	Same-day reporting (within 24 h)	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum creatinine", "eGFR (CKD-EPI)", "Urine albumin-to-creatinine ratio (ACR)"] Parameters [{"name": "Serum Creatinine", "reference_range": null}, {"name": "eGFR (CKD-EPI)", "reference_range": null}, {"name": "Urine Albumin-to-Creatinine Ratio (ACR)", "reference_range": null}] Preparation ["Fast for 8–10 hours", "Collect a first-morning urine sample between 8 and 10 AM", "Inform phlebotomist of recent strenuous exercise or high-protein meal"] Indications ["Screening for chronic kidney disease", "Monitoring kidney function in patients with risk factors (e.g., diabetes, hypertension)", "Staging chronic kidney disease", "Assessing kidney damage"] Measurement technique Confirm with laboratory Codes LOINC: 33914-3, 3097-7, 14959-1, 30000-4 ICD-10: N18.9 Clinical summary This diagnostic test evaluates kidney function and damage markers, including creatinine, estimated glomerular filtration rate (eGFR), and urine albumin-to-creatinine ratio (ACR).
TEST-2947 CLCF1 Gene Cold-Induced Sweating Syndrome Type 2 Genetic Test This test identifies pathogenic variants in the CLCF1 gene associated with Cold-Induced Sweating Syndrome Type 2.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CLCF1 gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of Cold-Induced Sweating Syndrome Type 2", "Documented family history of the disorder", "Genetic counselling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 101578-7 ICD-10: Q87.8, G90.8 Clinical summary This test identifies pathogenic variants in the CLCF1 gene associated with Cold-Induced Sweating Syndrome Type 2.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Biochemistry tests in Dubai & UAE

Biochemistry test prices

Biochemistry: overview

Use the test details as a conversation starter

Related Biochemistry categories